CLINICAL_TRIALS
trial_result
· 2025-08-08
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial data for tirzepatide in Chinese participants with type 2 diabetes has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Type 2, Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2025-08-08